This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Mullard A, Bishop J, Jibani M. Intractable malignant ascites: An alternative management option. J Palliative Med 2011; 2: 251–3.MullardABishopJJibaniMIntractable malignant ascites: An alternative management optionJ Palliative Med20112251310.1089/jpm.2010.0196Search in Google Scholar
O’Neill M, Weissleder R, Gervais D, Hahn P, Mueller P. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. Am J Roentgenol 2001; 177: 615–8.O’NeillMWeisslederRGervaisDHahnPMuellerPTunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascitesAm J Roentgenol2001177615810.2214/ajr.177.3.1770615Search in Google Scholar
Richard H, Coldwell D, Boyd-Kranis R, Murthy R, Van Echo D. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Intervent Radiol 2001: 12: 373–5.RichardHColdwellDBoyd-KranisRMurthyRVan EchoDPleurx tunneled catheter in the management of malignant ascitesJ Vasc Intervent Radiol200112373510.1016/S1051-0443(07)61919-8Search in Google Scholar
Belfort M, Stevens P, DeHaek K, Soeters R, Krige J. A new approach to the management of malignant ascites; a permanently implanted abdominal drain. Eur J Surg Oncol 1990; 16: 47–53.BelfortMStevensPDeHaekKSoetersRKrigeJA new approach to the management of malignant ascites a permanently implanted abdominal drainEur J Surg Oncol1990164753Search in Google Scholar
Arai Y, Inaba Y, Sone M, Saitoh H, Takeuchi Y, Shioyama Y, et al. Plase I/ II study of transjugular transhepatic peritoneovenous venous shunt, a new procedure to manage refractory ascites in cancer patients: Japan Interventional Radiology in Oncology Study Group 0201. Am J Roentgenol 2011; 196: W621–W626.AraiYInabaYSoneMSaitohHTakeuchiYShioyamaYPlase I/ II study of transjugular transhepatic peritoneovenous venous shunt, a new procedure to manage refractory ascites in cancer patients: Japan Interventional Radiology in Oncology Study Group 0201Am J Roentgenol2011196W621W62610.2214/AJR.10.4716Search in Google Scholar
Lorentzen T, Sengeløv L, Nolsøe CP, Khattar SC, Karstrup S, von der Maase H. Ultrasonically guided insertion of a peritoneo-gastric shunt in patients with malignant ascites. Acta Radiol 1995; 36:481–4.LorentzenTSengeløvLNolsøeCPKhattarSCKarstrupSvon der MaaseHUltrasonically guided insertion of a peritoneo-gastric shunt in patients with malignant ascitesActa Radiol199536481410.1177/028418519503600434Search in Google Scholar
Stehman F, Ehrlich C. Peritoneo-cystic shunt for malignant ascites. Gynecol Oncol 1984; 18: 402–7.StehmanFEhrlichCPeritoneo-cystic shunt for malignant ascitesGynecol Oncol198418402710.1016/0090-8258(84)90052-0Search in Google Scholar
Rosenberg S, Courtney A, Nemcek A, Omary R. Comparison of percutaneous management techniques for recurrent malignant ascites. J Vasc Intervent Radiol 2004; 15: 1129–31.RosenbergSCourtneyANemcekAOmaryRComparison of percutaneous management techniques for recurrent malignant ascitesJ Vasc Intervent Radiol20041511293110.1097/01.RVI.0000136828.42612.B415466800Search in Google Scholar
Tapping C, Ling L, Razack A. PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success. Br J Radiol 2012; 85: 623–8.TappingCLingLRazackAPleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of successBr J Radiol201285623810.1259/bjr/24538524347988521427184Search in Google Scholar
Lungren M, Kim C, Stewart J, Smith T, Miller M. Tunneled peritoneal drainage catheter placement for refractory ascites: Single-center experience in 188 patients. J Vasc Intervent Radiol 2014; 24: 1303–8.LungrenMKimCStewartJSmithTMillerMTunneled peritoneal drainage catheter placement for refractory ascites: Single-center experience in 188 patientsJ Vasc Intervent Radiol2014241303810.1016/j.jvir.2013.05.04223876552Search in Google Scholar
Courtney A, Nemcek A, Rosenberg S, Tutton S, Darcy M, Gordon G. Prospective evaluation of the PleurX catheter when used to treat malignant ascites associated with malignancy. J Vasc Intervent Radiol 2008; 19: 1723–31.CourtneyANemcekARosenbergSTuttonSDarcyMGordonGProspective evaluation of the PleurX catheter when used to treat malignant ascites associated with malignancyJ Vasc Intervent Radiol20081917233110.1016/j.jvir.2008.09.00218951041Search in Google Scholar
Savin M, Kirsch M, Romano W, Wang S, Arpasi P, Mazon C. Peritoneal ports for treatment of intractable ascites. J Vasc Intervent Radiol 2005; 16: 363–8.SavinMKirschMRomanoWWangSArpasiPMazonCPeritoneal ports for treatment of intractable ascitesJ Vasc Intervent Radiol200516363810.1097/01.RVI.0000147082.05392.2BSearch in Google Scholar
Ozkan O, Akinci D, Gocmen R, Cil B, Ozmen M, Akhan O. Percutaneous placement of peritoneal port-catheter in patients with malignant ascites. Cardiovasc Intervent Radiol 2007; 30: 232–6.OzkanOAkinciDGocmenRCilBOzmenMAkhanOPercutaneous placement of peritoneal port-catheter in patients with malignant ascitesCardiovasc Intervent Radiol200730232610.1007/s00270-005-0252-4Search in Google Scholar
Baumann K, Pfisterer J, Wimberger P, Burchardi N, Kurzeder C, du Bois A, et al. Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group. Gynecol Oncol 2011; 123: 27–32.BaumannKPfistererJWimbergerPBurchardiNKurzederCdu BoisAIntraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study GroupGynecol Oncol2011123273210.1016/j.ygyno.2011.06.004Search in Google Scholar
Barnett T, Rubins J. Placement of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: A simplified percutaneous approach. J Vasc Intervent Radiol 2002; 13: 379–83.BarnettTRubinsJPlacement of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: A simplified percutaneous approachJ Vasc Intervent Radiol2002133798310.1016/S1051-0443(07)61740-0Search in Google Scholar
Akinci D, Erol B, Ciftci T, Akhan O. Radiologically placed tunneled peritoneal catheter in palliation of malignant ascites. Eur J Radiol 2008; 80: 265–8.AkinciDErolBCiftciTAkhanORadiologically placed tunneled peritoneal catheter in palliation of malignant ascitesEur J Radiol200880265810.1016/j.ejrad.2010.06.04720692116Search in Google Scholar
Heiss M, Murawa P, Koralewski P, Kutarska E, Kolesnik O, Ivanchenko V, et al. The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial. Int J Cancer 2010; 127: 2209–21.HeissMMurawaPKoralewskiPKutarskaEKolesnikOIvanchenkoVThe trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trialInt J Cancer201012722092110.1002/ijc.25423295845820473913Search in Google Scholar
